At the ECCMID conference in Amsterdam, Beckman Coulter will host a symposium on AMR and sepsis.

Photo: Unsplash/Yannis Papanastasopoulos

News • Symposium @ ECCMID 2019

How laboratories can help detect AMR and sepsis sooner

Beckman Coulter, a global leader in clinical diagnostics will be demonstrating its latest comprehensive solutions in microbiology, urinalysis and hematology at the 29th European Congress of Clinical Microbiology & Infectious Diseases (ECCMID).

During the conference, Beckman Coulter is also hosting a symposium where attendees will learn how the laboratory can help physicians detect antimicrobial resistance (AMR) and sepsis sooner. Today's laboratories are facing more challenges than ever. Increasing concern over sepsis accelerates the need for accurate, rapid diagnosis. Coupled with the growing threat of emerging AMR, routine antibiotic susceptibility testing and minimum inhibitory concentration accuracy is needed to not only help detect AMR, but also to meet the clinical needs of all patients.

Recommended article


Article • Antibiotic resistance

End animal growth drugs to tackle superbugs

A major summit meeting in London, Great Britain, has seen politicians, doctors, scientists, farmers and other experts come together in a bid to tackle the growing global antimicrobial resistance (AMR) crisis. Among these experts was Dame Sally Davies, England’s Chief Medical Officer, who described AMR as a ‘problem without a face’ because most patients are not told they have a resistant…

The symposium entitled, New Challenges in Clinical Microbiology: Faster Diagnosis of Sepsis and Critical Routine Susceptibility Testing, will be held at 16:00 on Monday, April 15, 2019 in hall C in the RAI Amsterdam. Symposium participants include:

  • Chair: Professor Barbara L. Zimmer, Beckman Coulter, Inc.
  • Panelist: Professor Rafael Canton, Ph.D. Hospital Universitario Ramón y Cajal-IRYCIS
  • Panelist: Professor Samantha Sottotetti, Cystic Fibrosis Microbiology Laboratory, IRCCS Fondazione Cà Granda, Ospedale Maggiore Policlinico
  • Panelist: Jeannine Holden, M.D., MBA, chief medical officer, Beckman Coulter, Inc.
  • Panelist: Professor Dr. Sören Gatermann, Abteilung für Medizinische Mikrobiologie der Ruhr-Universität Bochum

Poster session

Beckman Coulter will present a series of microbiology posters on Monday, April 15 at 12:30pm, showcasing multicenter study data that confirms MicroScan Dried Gram-negative minimum inhibitory concentrations (MICs) deliver enhanced efficiency without sacrificing clinical microbiology test accuracy.

The MicroScan WalkAway system
Source: Beckman Coulter

At Booth #1.50, Beckman Coulter will be showcasing the following solutions:


  • DxM MicroScan WalkAway System
  • DxM 6100 Autoplak Advanced system
  • Bruker MALDI Biotyper system
  • SH2000TM Automated Microscan Panel Inoculation system
  • MicroScan autoSCAN-4 system


  • Early Sepsis Indicator available on the DxH 900 Hematology Analyzer


  • iRICELL 3000 Urinalysis Workcell

Source: Beckman Coulter


Read all latest stories

Related articles


Sponsored • 100th DxA Automation System installed

Automation reimagines laboratory diagnostics service

San Paolo Hospital in Savona, Italy, has upgraded its Corelab-related analytical equipment. In collaboration with Beckman Coulter, the San Paolo diagnostic laboratory has installed Beckman…


Sponsored • Infection management

New sepsis marker speeds up detection and therapy

Sepsis is the cause of one in five deaths worldwide, killing nearly 11 million people each year, many of them children. It is also a major cause of disability, affecting millions more. To combat the…


Interview • Urinalysis for Covid-19 diagnostics

Automation to relieve pandemic pressure from laboratories

To provide a solution for the challenges of the coronavirus pandemic, Beckman Coulter recently launched the DxU Iris, a urinalysis solution which aims to improve lab workflows.

Related products

Subscribe to Newsletter